Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 2266 AL 2280

Suicide, Moral Injury, Parkinson's Disease, Diabetes and Dialysis

Carey LB, Hill T, Koenig HG, Drummond D, Gabbay E, Cohen J, Aiken C, Paal P.

J Relig Health. 2023 Dec;62(6):3703-3708. doi: 10.1007/s10943-023-01940-2. Epub 2023 Nov 10.

Sodium Oxybate in Alcohol-Responsive Essential Tremor of Voice: An Open-Label Phase II Study

O'Flynn LC, Frucht SJ, Simonyan K.

Mov Disord. 2023 Oct;38(10):1936-1944. doi: 10.1002/mds.29529. Epub 2023 Jul 14.

Human cerebrospinal fluid single exosomes in Parkinson's and Alzheimer's diseases

Yakabi K, Berson E, Montine KS, Bendall SC, MacCoss MJ, Poston KL, Montine TJ.

bioRxiv [Preprint]. 2023 Dec 23:2023.12.22.573124. doi: 10.1101/2023.12.22.573124.

Editorial: Prodromal stage of neurodegenerative proteinopathies: from bench to bedside

Xu B, Fereshtehnejad SM, Zeighami Y.

Front Neurosci. 2023 Sep 27;17:1295344. doi: 10.3389/fnins.2023.1295344. eCollection 2023.

Resting-state EEG measures cognitive impairment in Parkinson's disease

Anjum MF, Espinoza A, Cole R, Singh A, May P, Uc E, Dasgupta S, Narayanan N.

Res Sq [Preprint]. 2023 Mar 20:rs.3.rs-2666578. doi: 10.21203/rs.3.rs-2666578/v1.

Protective effects of polyphenol-rich extracts against neurotoxicity elicited by paraquat or rotenone in cellular models of Parkinson's disease

Tambe MA, de Rus Jacquet A, Strathearn KE, Yousef GG, Grace MH, Ferruzzi MG, Wu Q, Simon JE, Lila MA, Rochet JC.

bioRxiv [Preprint]. 2023 Apr 27:2023.04.26.538474. doi: 10.1101/2023.04.26.538474.

COVID-19 and neurological disorders: what might connect Parkinson's disease to SARS-CoV-2 infection

Iacono S, Schirò G, Davì C, Mastrilli S, Abbott M, Guajana F, Arnao V, Aridon P, Ragonese P, Gagliardo C, Colomba C, Scichilone N, D'Amelio M.

Front Neurol. 2023 May 18;14:1172416. doi: 10.3389/fneur.2023.1172416. eCollection 2023.

Editorial: The effect of gut microbiota on the brain structure and function

Liang S, Jin F, Jia C.

Front Integr Neurosci. 2023 Jun 29;17:1226664. doi: 10.3389/fnint.2023.1226664. eCollection 2023.

Editorial: Neuroprotective mechanisms by phytochemicals in neurological disorders

Kumar G.

Front Neurosci. 2023 Mar 16;17:1149639. doi: 10.3389/fnins.2023.1149639. eCollection 2023.

A novel brain penetrant c-Abl tyrosine kinase inhibitor: Paving a path forward to success in disease modification in Parkinson's disease

Simuni T, Merchant K.

Parkinsonism Relat Disord. 2023 Mar;108:105325. doi: 10.1016/j.parkreldis.2023.105325. Epub 2023 Feb 16.

Physical exercise for treating non-motor symptoms assessed by general Parkinson's disease scales: systematic review and meta-analysis of clinical trials

Costa V, Suassuna AOB, Brito TSS, da Rocha TF, Gianlorenco AC.

BMJ Neurol Open. 2023 Oct 4;5(2):e000469. doi: 10.1136/bmjno-2023-000469. eCollection 2023.

Editorial: Non-coding RNAs in diseases of the nervous system

Reschke CR, Chowdhury EH, Lee AYW.

Front Cell Neurosci. 2023 Jun 9;17:1226950. doi: 10.3389/fncel.2023.1226950. eCollection 2023.

Antiglycoxidative properties of amantadine - a systematic review and comprehensive in vitro study

Nesterowicz M, Żendzian-Piotrowska M, Ładny JR, Zalewska A, Maciejczyk M.

J Enzyme Inhib Med Chem. 2023 Dec;38(1):138-155. doi: 10.1080/14756366.2022.2137161.

The regulatory role of non-coding RNAs and their interactions with phytochemicals in neurodegenerative diseases: a systematic review

Fakhri S, Darvish E, Narimani F, Moradi SZ, Abbaszadeh F, Khan H.

Brief Funct Genomics. 2023 Apr 13;22(2):143-160. doi: 10.1093/bfgp/elac055.

Gut Microbiota is an Impact Factor based on the Brain-Gut Axis to Alzheimer's Disease: A Systematic Review

Zou B, Li J, Ma RX, Cheng XY, Ma RY, Zhou TY, Wu ZQ, Yao Y, Li J.

Aging Dis. 2023 Jun 1;14(3):964-1678. doi: 10.14336/AD.2022.1127.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias